Overview
- 4 public-safe observations are available for this inspection.
- 4 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
12 May 2010
21 CFR 211.22(d)
Procedures not in writing, fully followed
Cited by Sarah M Napier, Patsy J Domingo
12 May 2010
21 CFR 211.160(b)
Scientifically sound laboratory controls
Cited by Sarah M Napier, Patsy J Domingo
12 May 2010
21 CFR 211.160(b)(1)
Samples (various types) representative, identified properly
Cited by Sarah M Napier, Patsy J Domingo
12 May 2010
21 CFR 211.170(b)
Annual visual exams of drug products
Cited by Sarah M Napier, Patsy J Domingo
Inspected site
TLTower Laboratories Ltd.Montague, United States
Inspection team
PJPatsy J Domingo
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.170(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 4 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere